Mathieu Le Gars
Impact in
- Obstetrics and Gynecology top 10%
- COVID-19 Impact on Reproduction
-
- Reproductive System and Pregnancy
- Immune Response and Inflammation
- Immune Cell Function and Interaction
Papers in
-
- SARS-CoV-2 and COVID-19 Research 11
- COVID-19 Clinical Research Studies 6
- Viral gastroenteritis research and epidemiology 4
-
- Influenza Virus Research Studies 5
- Co-authors
- Michel Chignard (2 shared papers)Jean‐Michel Sallenave (2 shared papers)Delphyne Descamps (2 shared papers)Catherine A. Blish (3 shared papers)Sophia Maschalidi (1 shared paper)Viviane Balloy (2 shared papers)Mira Tohmé (1 shared paper)Bénédicte Manoury (1 shared paper)
- Journals
- Vaccine (4 papers)Human Vaccines & Immunotherapeutics (2 papers)The Journal of Infectious Diseases (2 papers)iScience (1 paper)Clinical Pharmacology & Therapeutics (1 paper)
- Partner nations
- United StatesNetherlandsBelgium
In The Last Decade
Mathieu Le Gars
19 papers receiving 312 citations
Peers
Comparison fields: 5 of 65
- Obstetrics and Gynecology 43
- Immunology 110
- Infectious Diseases 63
- Emergency Medical Services 23
- Pulmonary and Respiratory Medicine 105
Countries citing papers authored by Mathieu Le Gars
This map shows the geographic impact of Mathieu Le Gars's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mathieu Le Gars with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mathieu Le Gars more than expected).
Fields of papers citing papers by Mathieu Le Gars
This network shows the impact of papers produced by Mathieu Le Gars. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mathieu Le Gars. The network helps show where Mathieu Le Gars may publish in the future.
Co-authors
The 25 scholars most cited alongside Mathieu Le Gars, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 21 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2012 | 84 | |
| 2 | 2012 | 81 | |
| 3 | 2016 | 38 | |
| 4 | 2019 | 34 | |
| 5 | 2021 | 17 | |
| 6 | 2022 | 14 | |
| 7 | 2022 | 14 | |
| 8 | 2022 | 7 | |
| 9 | 2022 | 5 | |
| 10 | 2023 | 4 | |
| 11 | 2023 | 4 | |
| 12 | 2016 | 4 | |
| 13 | 2024 | 2 | |
| 14 | 2022 | 2 | |
| 15 | 2024 | 2 | |
| 16 | 2025 | 1 | |
| 17 | 2025 | 1 | |
| 18 | 2025 | 1 | |
| 19 | 2017 | 1 | |
| 20 | 2025 | 0 |
About Mathieu Le Gars
Mathieu Le Gars is a scholar working on Infectious Diseases, Epidemiology, Immunology, Molecular Biology and Health, having authored 21 papers that have together received 316 indexed citations. Recurring topics across this work include SARS-CoV-2 and COVID-19 Research (11 papers), COVID-19 Clinical Research Studies (6 papers), Influenza Virus Research Studies (5 papers), Viral gastroenteritis research and epidemiology (4 papers), Vaccine Coverage and Hesitancy (3 papers), Virus-based gene therapy research (2 papers), Immune Cell Function and Interaction (2 papers) and Reproductive System and Pregnancy (2 papers). The work is most often cited by research in Obstetrics and Gynecology (43 citations), Immunology (110 citations), Infectious Diseases (63 citations), Emergency Medical Services (23 citations) and Pulmonary and Respiratory Medicine (105 citations). Mathieu Le Gars has collaborated with scholars based in United States, Netherlands and Belgium. Frequent co-authors include Michel Chignard, Jean‐Michel Sallenave, Delphyne Descamps, Catherine A. Blish, Sophia Maschalidi, Viviane Balloy, Mira Tohmé, Bénédicte Manoury, Diane Barbier and Reuben Ramphal. Their work appears in journals such as Vaccine, Human Vaccines & Immunotherapeutics, The Journal of Infectious Diseases, iScience and Clinical Pharmacology & Therapeutics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.